Cargando…
PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia
CONTEXT: Postbariatric hypoglycemia (PBH), characterized by enteroinsular axis overstimulation and hyperinsulinemic hypoglycemia, is a complication of bariatric surgery for which there is no approved therapy. OBJECTIVE: To evaluate efficacy and safety of avexitide [exendin (9-39)], a glucagon-like p...
Autores principales: | Craig, Colleen M, Lawler, Helen Margaret, Lee, Clare Jung Eun, Tan, Marilyn, Davis, Dawn Belt, Tong, Jenny, Glodowski, Michele, Rogowitz, Elisa, Karaman, Rowan, McLaughlin, Tracey L, Porter, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277203/ https://www.ncbi.nlm.nih.gov/pubmed/33616643 http://dx.doi.org/10.1210/clinem/dgab103 |
Ejemplares similares
-
OR20-5 28-Day Dosing with Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients with Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study
por: Lee, Clare, et al.
Publicado: (2019) -
OR03-4 Efficacy and Safety of Avexitide for Treatment of Hypoglycemia after Gastrointestinal Surgery; Assessment of Novel Dosing Regimens in an Expanded Indication
por: Craig, Colleen, et al.
Publicado: (2022) -
FRI664 The Impact Of Prediabetes Diagnosis On The Prevalence Of Postbariatric Hypoglycemia
por: Reshma Shariff, Julia Rose, et al.
Publicado: (2023) -
Digital Solutions to Diagnose and Manage Postbariatric Hypoglycemia
por: Schönenberger, Katja A., et al.
Publicado: (2022) -
Postbariatric hypoglycemia in symptomatic versus asymptomatic patients: proposals for clinical assessments
por: Uddén Hemmingsson, Joanna, et al.
Publicado: (2022)